Improving Cardiac Health Through Early Detection
Cardiovascular disease is the leading cause of death worldwide and coronary artery calcification (CAC) affects 25 million Americans annually with over half of incidental findings not reported. In addition, COPD is a massive global health issue, with a prevalence of over 400 million and is the fourth leading cause of death worldwide. Unquestionably, the best possible treatment of cardiac patients stems from the earliest possible detection. ClearRead Chest is a total chest health AI suite designed for pulmonary nodule detection, pneumothorax, and coronary artery calcification (CAC) scoring. Riverain's AI-driven technology eliminates the barriers that often stand in the way of clear and accurate X-ray and CT scans while reducing radiologists' time that's typically spent to inspect and evaluate pulmonary nodules.